U.S. Online Retail and Ecommerce Stock News

What Is Moving National HealthCare Stock Right Now? National HealthCare (NHC) has drawn investor attention recently as the stock price and valuation metrics have shifted. This is prompting a closer look at how its current market pricing compares with reported fundamentals. See our latest analysis for National HealthCare. Recent trading in National HealthCare shows strong momentum, with a 30 day share price return of 6.07%, a 90 day share price return of 25.15%, and a 1 year total shareholder...

Earlier this week at the BIO International Convention 2026 in San Diego, Thermo Fisher Scientific showcased upgrades to its Orbitrap mass spectrometry platform, new AI-powered software, and integrated laboratory solutions aimed at supporting complex research and biopharma development. This push to act as a single, AI-enabled partner across drug discovery, clinical development, and bioproduction highlights Thermo Fisher’s effort to deepen its role in end-to-end pharmaceutical workflows. We’ll...

Why ESAB’s New Board Roles Matter for Investors ESAB (ESAB) recently reshaped its board leadership, appointing Mitchell P. Rales as Executive Chair and Rhonda Jordan as Lead Independent Director. These moves focus attention on the company’s governance and ongoing transformation. For investors tracking ESAB stock, these appointments highlight how the board intends to organize oversight, clarify leadership roles, and support the existing management team as it pursues the company’s growth and...

Five Star Bancorp has opened a new full-service branch in Lodi, California, to deepen its banking support for local entrepreneurs and agribusinesses in the Central Valley. This move reinforces the bank’s focus on relationship-based lending in agriculture-rich communities, particularly vineyards and nut and cherry producers around Lodi. Next, we’ll examine how the Lodi branch opening, with its emphasis on agribusiness lending, may influence Five Star Bancorp’s investment narrative. Uncover...

Recent commentary on American Tower (AMT) is putting fresh focus on how its global tower network and data center portfolio intersect with rising 5G deployment, cloud computing demand, and AI driven workloads. See our latest analysis for American Tower. Despite the focus on 5G and AI infrastructure, American Tower’s recent share price has been under pressure. The 30 day share price return is down 8.78% and the 1 year total shareholder return is down 19.44%, pointing to fading momentum as...

BXP (BXP) stock is back in focus after the company signed a long term lease with Boston Dynamics for about 320,000 square feet at Reservoir Place in Waltham, Massachusetts. See our latest analysis for BXP. BXP’s latest leasing wins with Boston Dynamics and McDermott Will & Schulte come as momentum in the stock has recently improved, with a 30 day share price return of 8.35% and a 90 day gain of 27.69%. However, the year to date share price is still down 3.17% and the 5 year total shareholder...

LivaNova recently reported new clinical data showing that its PolySync programming algorithm increased the cumulative apnea-hypopnea index response rate to 84.5% in moderate to severe Obstructive Sleep Apnea patients treated with proximal hypoglossal nerve stimulation, with no serious treatment-emergent or device-related adverse events, based on OSPREY trial reprogramming results presented at SLEEP 2026. The findings underscore how PolySync’s simultaneous-contact stimulation and six-contact...

Earlier this month, La-Z-Boy Incorporated reported fourth-quarter 2026 sales of US$570.34 million with net income of US$33.27 million, raised its quarterly dividend for the fifth consecutive year, launched a new US$300 million share repurchase authorization, and disclosed continued activity under its long-running buyback program. Together, higher quarterly earnings, ongoing dividend growth, and a sizable new repurchase plan underscore management’s commitment to returning cash to shareholders...

NovoCure (NVCR) stock is in focus after the company reported topline Phase 3 TRIDENT data showing no statistically significant overall survival benefit from earlier initiation of Tumor Treating Fields in newly diagnosed glioblastoma. See our latest analysis for NovoCure. For context, NovoCure’s share price has been volatile, with a 5.39% 7 day share price return and a 37.19% 90 day share price return, but a 1 year total shareholder return that declined 11.99%, suggesting recent momentum...

Wondering whether Advanced Micro Devices stock still offers value after a strong run, or if expectations have already been priced in? This article walks through what the numbers are actually saying about the current valuation. AMD's share price last closed at US$532.57, with the stock down 0.9% over the past week but up 5.7% over 30 days, 138.3% year to date and 270.7% over the last year. Recent headlines around Advanced Micro Devices have focused on its position in high performance...

Autohome Inc. recently held its 2025 annual general meeting, where shareholders approved replacing the Seventh Amended and Restated Memorandum and Articles of Association with an Eighth edition and re‑elected key board members. This overhaul of the corporate bylaws, alongside management’s emphasis on user growth, new transaction features, and overseas platforms, could reshape how Autohome governs and scales its business. Next, we’ll examine how Autohome’s updated corporate bylaws and...

Regulators are turning up the heat on lithium batteries in everyday travel gear, from power banks to vapes, and that shift could matter for your portfolio. As scrutiny on safety rises, weaker suppliers may struggle to keep up, while certified battery manufacturers and established electronics brands could stand out with products that meet higher expectations. This article looks at how that changing backdrop connects to the Certified Battery Manufacturers & Electronic Device Brands screener and...

Alpha Tau Medical’s glioblastoma milestone and what it means for investors Alpha Tau Medical (NasdaqCM:DRTS) has attracted fresh investor attention after reporting the first successful Alpha DaRT treatment of a recurrent glioblastoma patient in Israel, and the first outside the United States. The procedure used the company’s brain specific delivery system at Hadassah University Medical Center in Jerusalem, targeting a recurrent tumor via a minimally invasive burr hole while maintaining real...

MSC Industrial Direct (MSM) reaffirmed its shareholder payout plans with a quarterly dividend of $0.87 per share, coinciding with heightened analyst expectations ahead of the company’s upcoming May 2026 quarter earnings release. See our latest analysis for MSC Industrial Direct. Recent trading in MSC Industrial Direct has been strong, with a 30 day share price return of 9.73% and a 90 day share price return of 32.19%. The 1 year total shareholder return of 46.45% reflects momentum that has...

In recent weeks, Fannie Mae and Freddie Mac have expanded their retained investment portfolios, pushing their interest-rate risk exposure to levels reminiscent of the early 2000s as policymakers seek to lower mortgage rates by reducing mortgage-backed securities supply. This shift means the government-backed mortgage giants are now carrying materially higher sensitivity to sharp rate moves, even as they operate with larger capital buffers and smaller portfolios than before the 2008 financial...

Crane (CR) is back in focus after DA Davidson reaffirmed its positive view on the stock and added the company to its Best-of-Breed Bison List, spotlighting growth and flexibility. See our latest analysis for Crane. Crane’s recent inclusion on DA Davidson’s Best-of-Breed Bison List comes as momentum builds, with a 30-day share price return of 23.02% and a 5-year total shareholder return of 290.81% pointing to strong long-term wealth creation. If Crane’s recent gains have you rethinking your...

Las Vegas Sands (LVS) stock has faced sustained pressure recently, with shares down about 3% over the past day, 5% over the past week, and roughly 7% over the past month. See our latest analysis for Las Vegas Sands. Zooming out, Las Vegas Sands has seen its share price weaken in recent months, with a year-to-date share price return of -29.03%, even though the 1-year total shareholder return is still 8.22%. If you are weighing Las Vegas Sands against other opportunities in the market, this...

Earlier this year, Stock Yards Bancorp reported quarterly revenues of US$102.6 million, representing 9.6% year-on-year growth, with net interest income matching analyst expectations. The bank emphasized that these results capped its best year in history and showed it entering 2026 with strong operating momentum. Next, we’ll examine how this revenue growth and “best year” commentary shape Stock Yards Bancorp’s investment narrative for investors. Capitalize on the AI infrastructure supercycle...

Earlier this week, Carvana announced it is adding Inspection and Reconditioning Center capabilities to its long‑running ADESA Sarasota wholesale auction site in Bradenton, Florida, creating extra reconditioning capacity, a new local retail inventory pool and around 100 new jobs over time. By layering its CARLI software platform onto the 60‑acre Sarasota facility, Carvana is effectively turning a traditional auction site into a dual‑purpose hub that can support faster local delivery, richer...

Earlier in June 2026, Pharvaris reported Phase 3 RAPIDe-3 data and long-term extension results at EAACI, highlighting rapid symptom relief, sustained hereditary angioedema control, and supportive cardiovascular safety findings for oral deucrictibant in both on-demand and prophylactic use. An especially interesting insight was that nearly half of interviewed RAPIDe-3 participants described an improved day-to-day treatment experience with oral deucrictibant versus prior injectable therapies,...

These clinical-stage biotech stocks focused on Parkinson's research feature treatments already in human trials, where clinical milestones could turn into meaningful share price catalysts.

After a long stretch where Wendy's stock has fallen about 60% over the past five years, valuation checks now suggest the shares may be pricing in a lot of pessimism, with both an intrinsic value estimate and earnings multiples pointing to potential undervaluation.

Expeditors International of Washington stock has climbed 43.8% over the past year, yet the valuation checks point to a company that no longer looks obviously cheap, with the Discounted Cash Flow (DCF) estimate sitting close to the current share price while market multiples lean richer....

Recent Price Moves Put Diamondback Energy in Focus Recent share price moves have put Diamondback Energy (FANG) on investors’ radar, with the stock down about 6% over the past month and roughly 10% over the past 3 months. See our latest analysis for Diamondback Energy. Despite the recent pullback, Diamondback Energy’s 1-year total shareholder return of 32.93% and 5-year total shareholder return of 126.57% show the share price weakness is coming after a strong multi year run. This suggests that...